Hannah King
Biomolecular Science
Instructor & Research Lab Coordinator
Biography
Hannah King serves as an Instructor and Research Coordinator at Lipscomb University, where she has been a valued member of the Biology Department since 2016. Hannah's academic journey began at Lipscomb University, where she earned a double major in Molecular Biology and Applied Biochemistry in 2013. She further honed her expertise by completing a Master's in Biomolecular Science from Lipscomb University in 2018, and a graduate certificate in Epidemiology from East Tennessee State University in 2022. Before joining Lipscomb University, Hannah spent three years as a Research Assistant at Vanderbilt University, focusing on antibody design and vaccine development. This experience laid a solid foundation for her current research coordination responsibilities. In her instructional role, Hannah teaches biostatistics in the Biomolecular Science program and leads Principles of Biology: Cell & Genetics labs for the Biology Department. She is particularly passionate about demystifying data analysis tools for her students, helping them overcome apprehensions about software like Excel and SAS. Her commitment to excellence in statistical education is evidenced by her certification as a SAS educator in 2023. Hannah and her husband, Sam, started dating in high school and have been married since 2013. They have two sons together who keep them busy. In her free time, Hannah enjoys gardening, camping, and running.
Academic Degrees
- B.S. in Molecular Biology and Applied Biochemistry- Lipscomb University (2013)
- M.S. in Biomolecular Science – Lipscomb University (2018)
- Graduate Certificate in Epidemiology- East Tennessee State University (2022)
Academic Department
Biology
Journal Articles:
- Chukwuma VU, Kose N, Sather DN, Sapparapu G, Falk R, King H, Singh V, Lampley R, Malherbe DC, Ditto NT, Sullivan JT, Barnes T, Doranz BJ, Labranche CC, Montefiori DC, Kalams SA, Haigwood NL, Crowe JE Jr. Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth. PLoS One. 2018 Dec 19;13(12):e0209437. doi: 10.1371/journal.pone.0209437. PMID: 30566528; PMCID: PMC6300260. https://pubmed.ncbi.nlm.nih.gov/30566528/
- Flyak AI, Kuzmina N, Murin CD, Bryan C, Davidson E, Gilchuk P, Gulka CP, Ilinykh PA, Shen X, Huang K, Ramanathan P, Turner H, Fusco ML, Lampley R, Kose N, King H, Sapparapu G, Doranz BJ, Ksiazek TG, Wright DW, Saphire EO, Ward AB, Bukreyev A, Crowe JE Jr. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Nat Microbiol. 2018 Jun;3(6):670-677. doi: 10.1038/s41564-018-0157-z. Epub 2018 May 7. PMID: 29736037; PMCID: PMC6030461. https://pubmed.ncbi.nlm.nih.gov/29736037/
- Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, Ohi MD, Meiler J, Crowe JE Jr. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6849-E6858. doi: 10.1073/pnas.1609449113. Epub 2016 Oct 17. PMID: 27791117; PMCID: PMC5098655. https://pubmed.ncbi.nlm.nih.gov/27791117/
- Bangaru S, Nieusma T, Kose N, Thornburg NJ, Finn JA, Kaplan BS, King HG, Singh V, Lampley RM, Sapparapu G, Cisneros A 3rd, Edwards KM, Slaughter JC, Edupuganti S, Lai L, Richt JA, Webby RJ, Ward AB, Crowe JE Jr. Recognition of influenza H3N2 variant virus by human neutralizing antibodies. JCI Insight. 2016 Jul 7;1(10):e86673. doi: 10.1172/jci.insight.86673. PMID: 27482543; PMCID: PMC4962875. https://pubmed.ncbi.nlm.nih.gov/27482543/
- Willis JR, Finn JA, Briney B, Sapparapu G, Singh V, King H, LaBranche CC, Montefiori DC, Meiler J, Crowe JE Jr. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization. Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4446-51. doi: 10.1073/pnas.1518405113. Epub 2016 Apr 4. PMID: 27044078; PMCID: PMC4843476. https://pubmed.ncbi.nlm.nih.gov/27044078/
- Flyak AI, Shen X, Murin CD, Turner HL, David JA, Fusco ML, Lampley R, Kose N, Ilinykh PA, Kuzmina N, Branchizio A, King H, Brown L, Bryan C, Davidson E, Doranz BJ, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Saphire EO, Ward AB, Bukreyev A, Crowe JE Jr. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell. 2016 Jan 28;164(3):392-405. doi: 10.1016/j.cell.2015.12.022. Epub 2016 Jan 21. PMID: 26806128; PMCID: PMC4733404. https://pubmed.ncbi.nlm.nih.gov/26806128/
- Willis JR, Sapparapu G, Murrell S, Julien JP, Singh V, King HG, Xia Y, Pickens JA, LaBranche CC, Slaughter JC, Montefiori DC, Wilson IA, Meiler J, Crowe JE Jr. Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth. J Clin Invest. 2015 Jun;125(6):2523-31. doi: 10.1172/JCI80693. Epub 2015 May 18. PMID: 25985274; PMCID: PMC4497764. https://pubmed.ncbi.nlm.nih.gov/25985274/
- Conway RE, Joiner K, Patterson A, Bourgeois D, Rampp R, Hannah BC, McReynolds S, Elder JM, Gilfilen H, Shapiro LH. Prostate specific membrane antigen produces pro-angiogenic laminin peptides downstream of matrix metalloprotease-2. Angiogenesis. 2013 Oct;16(4):847-60. doi: 10.1007/s10456-013-9360-y. Epub 2013 Jun 18. PMID: 23775497. https://pubmed.ncbi.nlm.nih.gov/23775497/
Book Chapters
- Gilfilen, H., Lavender, K., Clinger, J., & Clinger, K. (2013). Bioanalytical Chemistry in Instrumental and Biochemistry Laboratories (Vol. 1137, pp. 139–154). essay. https://pubs.acs.org/doi/abs/10.1021/bk-2013-1137.ch007
